Emil Kakkis
Gründer bei ULTRAGENYX PHARMACEUTICAL INC.
Vermögen: 119 Mio $ am 30.04.2024
Profil
Emil D. Kakkis gründete Ultragenyx Pharmaceutical, Inc. und die Everylife Foundation for Rare Diseases. Dr. Kakkis bekleidet die Position des President, Chief Executive Officer & Director bei Ultragenyx Pharmaceutical, Inc. Dr. Kakkis ist außerdem im Vorstand des Emil Kakkis & Jenny Soriano Living Trust und von Odylia Therapeutics sowie Präsident der Everylife Foundation for Rare Diseases. In seiner früheren Karriere war Dr. Kakkis Chief Medical Officer & Senior Vice President bei BioMarin Pharmaceutical, Inc. und Assistenzprofessor am Harbor-UCLA Medical Center. Dr. Kakkis erwarb einen Bachelor-Abschluss am Pomona College und einen Doktortitel an der David Geffen School of Medicine.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 12.04.2024 | 2 724 300 ( 3,31% ) | 119 Mio $ | 30.04.2024 |
Aktive Positionen von Emil Kakkis
| Unternehmen | Position | Beginn |
|---|---|---|
| ULTRAGENYX PHARMACEUTICAL INC. | Gründer | 22.04.2010 |
| Emil Kakkis & Jenny Soriano Living Trust | Direktor/Vorstandsmitglied | - |
Everylife Foundation for Rare Diseases
 Everylife Foundation for Rare Diseases Miscellaneous Commercial ServicesCommercial Services EveryLife Foundation for Rare Diseases is a non-profit organization that aims to advance the development of treatment and diagnostic opportunities for rare disease patients through science-driven public policy. The non-profit company is based in Novato, CA and was founded by Emil D. Kakkis. The foundation provides training, education, resources, and opportunities to make patient voices heard, with the belief that activating the patient advocate can change public policy and save lives. | Gründer | 01.03.2009 |
| Odylia Therapeutics | Direktor/Vorstandsmitglied | 01.01.2019 |
Ehemalige bekannte Positionen von Emil Kakkis
| Unternehmen | Position | Ende |
|---|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Technik-/Wissenschafts-/F&E-Leiter | 27.02.2009 |
Harbor-UCLA Medical Center
 Harbor-UCLA Medical Center Medical/Nursing ServicesHealth Services Harbor-UCLA Medical Center provides medical practice, education, and research services. The private company is based in Torrance, CA. | Corporate Officer/Principal | 01.01.1998 |
Ausbildung von Emil Kakkis
| Pomona College | Undergraduate Degree |
| David Geffen School of Medicine | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Health Technology |
| ULTRAGENYX PHARMACEUTICAL INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Harbor-UCLA Medical Center
Harbor-UCLA Medical Center Medical/Nursing ServicesHealth Services Harbor-UCLA Medical Center provides medical practice, education, and research services. The private company is based in Torrance, CA. | Health Services |
| Emil Kakkis & Jenny Soriano Living Trust | |
Everylife Foundation for Rare Diseases
Everylife Foundation for Rare Diseases Miscellaneous Commercial ServicesCommercial Services EveryLife Foundation for Rare Diseases is a non-profit organization that aims to advance the development of treatment and diagnostic opportunities for rare disease patients through science-driven public policy. The non-profit company is based in Novato, CA and was founded by Emil D. Kakkis. The foundation provides training, education, resources, and opportunities to make patient voices heard, with the belief that activating the patient advocate can change public policy and save lives. | Commercial Services |
| Odylia Therapeutics |
